Md. Norris et al., Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model, MED PED ONC, 35(6), 2000, pp. 585-589
Background. Although the association between N-myc gene amplification and p
oor clinical outcome in neuroblastoma is well established, the mechanism by
which amplification influences prognosis is not well defined. Procedure. W
e used a human N-myc transgenic mouse model to investigate the role of N-my
c in neuroblastoma, including its relationship to the multidrug-resistance-
associated protein (MRP) gene. We developed a rapid realtime PCR method to
distinguish homozygous and hemizygous N-myc mice that is comparable to Sout
hern analysis. Results. A highly significant correlation (P < 0.0001) betwe
en N-myc and MRP expression was demonstrated in murine tumors. Amplificatio
n of the transgene was observed in the majority of tumors, high lighting th
e clinical relevance of this model. However, no correlation between N-myc e
xpression and transgene dosage or tumor latency was observed. Conclusions.
The data suggest that increased N-myc dosage contributes to increased tumor
incidence and decreased latency by mechanisms independent of N-myc express
ion. (C) 2000 Wiley-Liss, Inc.